California Nanotechnologies Announces Dr. Lavernia Resigns as Director
04 Janvier 2017 - 1:16AM
The Company would like to note that Dr. Enrique Lavernia has
resigned as a director of California Nanotechnologies Corp.,
effective January 1, 2017. "Dr. Lavernia has made a tremendous
contribution to Cal Nano over the last several years. While
stepping down as a Director, it is hoped that the strong
collaborative efforts that were initiated years ago will continue,"
stated David Grant, Chairman of the Board. "I'm sure I speak for
the entire Board in thanking Dr. Lavernia for his multifaceted
support of the Company."
For further information, please
contact:
Mr. Mikel Damke, Executive Assistant to the CEOTel.
No. (403) 660-7770, or (888) 660-7770Email:
m.damke@calnanocorp.comWebsite: www.calnanocorp.com
For additional information, please
contact:
Mr. David Grant, Interim CEOTel. No. (562) 404-8510
or (800) 577-6664 Fax. No. (562) 926-6913 Email:
d.grant@omni-lite.comWebsite: www.calnanocorp.com
Reader Advisory
Except for statements of historical fact, this news
release contains certain "forward-looking information" within the
meaning of applicable securities law. Forward-looking information
is frequently characterized by words such as "plan", "expect",
"project", "intend", "believe", "anticipate", "estimate" and other
similar words, or statements that certain events or conditions
"may" or "will" occur. In particular, forward-looking information
in this press release includes, but is not limited to the expected
future performance of the Company. Although we believe that the
expectations reflected in the forward-looking information are
reasonable, there can be no assurance that such expectations will
prove to be correct. We cannot guarantee future results,
performance or achievements. Consequently, there is no
representation that the actual results achieved will be the same,
in whole or in part, as those set out in the forward-looking
information. Forward-looking information is based on the opinions
and estimates of management at the date the statements are made,
and are subject to a variety of risks and uncertainties and other
factors that could cause actual events or results to differ
materially from those anticipated in the forward-looking
information. Some of the risks and other factors that could cause
the results to differ materially from those expressed in the
forward-looking information include, but are not limited to:
general economic conditions in Canada, the United States and
globally; industry conditions, governmental regulation, including
environmental regulation; unanticipated operating events or
performance; failure to obtain industry partner and other third
party consents and approvals, if and when required; the
availability of capital on acceptable terms; the need to obtain
required approvals from regulatory authorities; stock market
volatility; competition for, among other things, capital, skilled
personnel and supplies; changes in tax laws; and the other risk
factors disclosed under our profile on SEDAR at www.sedar.com.
Readers are cautioned that this list of risk factors should not be
construed as exhaustive.
The forward-looking information contained in this
news release is expressly qualified by this cautionary statement.
We undertake no duty to update any of the forward-looking
information to conform such information to actual results or to
changes in our expectations except as otherwise required by
applicable securities legislation. Readers are cautioned not to
place undue reliance on forward-looking information.
Neither TSX Venture Exchange nor its
Regulation Services Provider (as that term is defined in policies
of the TSX Venture Exchange) accepts responsibility for the
adequacy or accuracy of this release.
E. INFO@CALNANOCORP.COM
P. 562.991.5211
F. 562.926.6913
W. WWW.CALNANOCORP.COM
California Nanotechnolog... (TSXV:CNO)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024
California Nanotechnolog... (TSXV:CNO)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024